Stephanie has over 15 years of research experience and has a passion for studying the central nervous system. Most recently she was at Intra-Cellular Therapies, Inc. where she worked with the clinical operations team to advance the Lumateperone Bipolar Disorder Depression Program to sNDA submission. After its approval, for use in adults with schizophrenia, she also lead several CAPLYTA (lumateperone) post-marketing-requirement studies. Prior to her clinical research in psychiatry Stephanie studied dementia, including Alzheimer’s Disease, and lead NIH funded, industry sponsored, and public-private partnership clinical studies and contributed to neuroimaging and genetic biomarker discoveries. Stephanie earned her bachelor’s degree in psychology from San Francisco State University. She served as an undergraduate researcher in the Department of Psychology at SFSU, the Department of Social Psychology at Stanford University, and Stanford University School of Medicine, Neurosciences.